新龙生物 (833098.OC)

+ 收藏

现金流量表(新龙生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 19,818,681.14106,560,504.9049,358,301.02108,801,108.6222,342,178.50
 收到其他与经营活动有关的现金(元) 40,150,353.5348,028,195.0937,357,939.2542,909,755.2965,668,100.08
 经营活动现金流入小计(元) 59,969,034.67154,588,699.9986,716,240.27151,710,863.9188,010,278.58
 购买商品、接受劳务支付的现金(元) 12,535,015.99120,424,725.3175,894,625.49160,120,599.9748,282,613.78
 支付给职工以及为职工支付的现金(元) 4,485,041.8310,121,301.614,232,614.0812,287,326.125,184,540.74
 支付的各项税费(元) 1,788,037.557,952,654.925,880,901.073,155,986.991,390,236.04
 支付其他与经营活动有关的现金(元) 49,425,244.3130,382,444.4822,501,967.4245,011,486.2082,396,599.55
 经营活动现金流出小计(元) 68,233,339.68168,881,126.32108,510,108.06220,575,399.28137,253,990.11
 经营活动产生的现金流量净额(元) -8,264,305.01-14,292,426.33-21,793,867.79-68,864,535.37-49,243,711.53
二、投资活动产生的现金流量
 收回投资收到的现金(元) --900,000.00--
 处置子公司及其他营业单位收到的现金净额(元) ---7,229,090.007,229,090.00
 收到其他与投资活动有关的现金(元) -6,196,330.00---
 投资活动现金流入小计(元) -6,196,330.00900,000.007,229,090.007,229,090.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 234,861.772,126,642.27600,849.0019,963,774.6710,078,946.23
 支付其他与投资活动有关的现金(元) ---4,700,000.00-
 投资活动现金流出小计(元) 234,861.772,126,642.27600,849.0024,663,774.6710,078,946.23
 投资活动产生的现金流量净额(元) -234,861.774,069,687.73299,151.00-17,434,684.67-2,849,856.23
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 32,200,000.0068,600,000.0033,000,000.0049,000,000.0023,000,000.00
 筹资活动现金流入小计(元) 32,200,000.0068,600,000.0033,000,000.0049,000,000.0023,000,000.00
 偿还债务支付的现金(元) 35,000,000.0057,500,000.0023,000,000.0038,500,000.0030,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 1,468,744.242,563,548.311,097,951.831,883,414.78876,847.97
 支付其他与筹资活动有关的现金(元) -272,101.09-278,367.123,000,000.00
 筹资活动现金流出小计(元) 36,468,744.2460,335,649.4024,097,951.8340,661,781.9033,876,847.97
 筹资活动产生的现金流量净额(元) -4,268,744.248,264,350.608,902,048.178,338,218.10-10,876,847.97
四、汇率变动对现金及现金等价物的影响(元) -5,121.29---
五、现金及现金等价物净增加额(元) -12,767,911.02-1,953,266.71-12,592,668.62-77,961,001.94-62,970,415.73
 加:期初现金及现金等价物余额(元) 13,340,713.0215,290,979.7315,290,979.7393,251,981.6793,251,981.67
 期末现金及现金等价物余额(元) 572,802.0013,337,713.022,698,311.1115,290,979.7330,281,565.94
补充资料:
 净利润(元) 6,263,385.4021,926,827.0915,326,286.2420,558,074.4911,878,267.69
 固定资产和投资性房地产折旧(元) 2,332,738.524,236,606.962,117,191.204,176,605.222,050,347.10
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,332,738.524,236,606.962,117,191.204,176,605.222,050,347.10
 无形资产摊销(元) 271,493.31718,333.73425,050.20850,100.40425,050.20
 长期待摊费用摊销(元) 38,333.3599,666.7153,666.6930,666.68-
 处置固定资产、无形资产和其他长期资产的损失(元) 6,995.50----
 固定资产报废损失(元) ---40,112.17-
 财务费用(元) 1,468,744.242,563,548.311,227,258.871,883,414.78942,142.16
 递延所得税(元) 69,206.25-4,149,664.64534,765.80-228,607.73-323,903.27
  其中:递延所得税资产减少(元) 69,206.25-4,149,664.64534,765.80-228,607.73-323,903.27
 存货的减少(元) 13,090,189.63-7,226,591.39-3,744,170.1526,281,452.631,567,517.85
 经营性应收项目的减少(元) -37,775,616.09-43,342,210.23-12,841,652.16-75,460,969.24-66,500,548.20
 经营性应付项目的增加(元) 4,949,158.69-5,147,337.33-26,344,611.45-56,851,887.31-8,337,217.35
 现金的期末余额(元) 572,802.0013,337,713.022,698,311.1115,290,979.7330,281,565.94
 减:现金的期初余额(元) 13,340,713.0215,290,979.7315,290,979.7393,251,981.6793,251,981.67
 现金及现金等价物的净增加额(元) -12,767,911.02-1,953,266.71-12,592,668.62-77,961,001.94-62,970,415.73
公告日期 2024-08-302024-04-252023-08-292023-04-252022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院